AVR 0.38% $15.65 anteris technologies ltd

annual general meeting review, page-27

  1. 715 Posts.
    lightbulb Created with Sketch. 3
    I agree entirely with stone and eagle. A lot of people on HC want instant results. Building a company takes years. The AGM presentation set out what the targets are over the next few years. The person complaining about the change of name (I thought it could have been meerkat) saying that the name doesn't mean anything, didn't utter a word when Coridon, Gardisil and Merck were mentioned - thoses names don't mean anything either. I thought the lady who is the Marketing Director did an excellent job explaining how the transitition from Allied to Admedus will occur with the branding. The capital A, hopefully, will in the future be as instantly recognised as the Nike swoosh.

    The board (messrs Catlow, Rodne, Rowley and Turvey -along with the sales, marketing and admin team) are doing a great job building a formidable company over the next few years.
    Instead of complaining about new names, number of shares on issue and wanting announcements every week, I think we should support what they're doing and let them carry on with their plan. They have the runs on the board both with other companies and so far with Admedus.

    Viva Admedus

 
watchlist Created with Sketch. Add AVR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.